ALGS vs SPG · rev $2.8M vs rev $1.79B
Aligos Therapeutics Inc (ALGS) versus SPG (SPG) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
SPG (SPG) common stock.
Latest reported ALGS revenue for 2026-06-30 was $2.8M. Net income was -$24.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. ALGS currently screens at market cap $44.1M.
Latest reported SPG revenue for 2025-12-31 was $1.79B. Net income was $3.54B. Revenue was up 13.2% from 2024-12-31 to 2025-12-31. SPG currently screens at market cap $0.
ALGS currently screens at market cap $44.1M. SPG currently screens at market cap $0.
Not investment advice. Open the ALGS and SPG stock pages for the full models.
Not investment advice.